Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 281: Patients taking a beta-adrenergic receptor blocking drug may experience all of the following except:

A. Exacerbation of existing heart block
B. Precipitation of heart failure
C. Nasal blockage (Correct Answer)
D. Cold extremities

Explanation: **Explanation:** Beta-adrenergic blockers (Beta-blockers) act by antagonizing $\beta_1$ and $\beta_2$ receptors. Understanding their side-effect profile requires mapping these receptors to their physiological locations. **Why "Nasal Blockage" is the Correct Answer:** Nasal patency is maintained by sympathetic stimulation of **$\alpha_1$ receptors**, which causes vasoconstriction of the nasal mucosa. Nasal blockage (congestion) is a classic side effect of **$\alpha$-blockers** (e.g., Prazosin) or Reserpine, not beta-blockers. Beta-blockers do not have a significant effect on the vasculature of the nasal mucosa. **Analysis of Incorrect Options:** * **Exacerbation of heart block (A):** $\beta_1$ receptors are responsible for conduction through the AV node. Blocking them (negative dromotropy) slows conduction, which can worsen pre-existing partial heart block or lead to complete heart block [1]. * **Precipitation of heart failure (B):** By blocking $\beta_1$ receptors in the myocardium, these drugs exert a negative inotropic effect (reduced contractility). In patients with compensated heart failure or borderline cardiac reserve, this sudden drop in contractility can precipitate acute decompensated heart failure [1]. * **Cold extremities (D):** This occurs due to two mechanisms: 1) Blockade of vascular $\beta_2$ receptors leads to unopposed $\alpha$-mediated vasoconstriction in peripheral vessels, and 2) Reduced cardiac output leads to reflex peripheral vasoconstriction. **NEET-PG High-Yield Pearls:** * **Propranolol** is the prototype non-selective beta-blocker. * **Contraindications:** Always remember the "ABCDE" of Beta-blocker contraindications: **A**sthma/COPD (due to $\beta_2$ blockade) [2], **B**lock (Heart block), **C**onstrictive peripheral vascular disease (Raynaud's), **D**ecompensated heart failure [1], and **E**lderly with Diabetes (masks hypoglycemic tachycardia) [1]. * **Lipid Profile:** Non-selective beta-blockers can increase TGs and decrease HDL.

Question 282: Vagal stimulation causes bradycardia, which can be blocked by?

A. atenolol
B. atropine (Correct Answer)
C. doxazosin
D. phenylephrine

Explanation: **Explanation:** The correct answer is **Atropine**. **Mechanism of Action:** Vagal stimulation (parasympathetic activity) leads to the release of **Acetylcholine (ACh)** at the sinoatrial (SA) node. ACh binds to **Muscarinic M2 receptors**, which are G-protein coupled receptors (Gi). This action decreases cAMP, opens potassium channels (hyperpolarization), and decreases the firing rate of the SA node, resulting in **bradycardia**. **Atropine** is a competitive antagonist of muscarinic receptors. By blocking the M2 receptors in the heart, it prevents ACh from binding, thereby inhibiting the vagal effect and increasing the heart rate (tachycardia). **Analysis of Incorrect Options:** * **A. Atenolol:** A selective $\beta_1$-blocker. It decreases heart rate by blocking sympathetic input. It would exacerbate bradycardia rather than block the vagal effect. * **C. Doxazosin:** A selective $\alpha_1$-blocker used primarily for hypertension and BPH. It acts on vascular smooth muscle and has no significant effect on vagal-mediated heart rate changes. * **D. Phenylephrine:** A selective $\alpha_1$-agonist. It causes vasoconstriction, which actually triggers a **reflex bradycardia** via the baroreceptor reflex (increased vagal tone). **NEET-PG High-Yield Pearls:** * **Drug of Choice:** Atropine is the first-line treatment for hemodynamically unstable sinus bradycardia. * **Paradoxical Effect:** Low doses of atropine can cause transient "paradoxical bradycardia" due to the blockade of presynaptic inhibitory M1 receptors on vagal nerve endings. * **Vagal Escape:** If the ventricles start beating at their own intrinsic rhythm during prolonged vagal stimulation, it is termed "vagal escape."

Question 283: Which class of autonomic drugs is used for reversing skeletal muscle relaxation caused by a nondepolarizing blocker?

A. Cholinesterase inhibitors (Correct Answer)
B. Parasympatholytics
C. Muscarinic antagonists
D. Sympatholytics

Explanation: **Explanation:** **Mechanism of Action (Why A is correct):** Nondepolarizing neuromuscular blockers (e.g., Vecuronium, Rocuronium) act as competitive antagonists at the nicotinic acetylcholine receptors ($N_m$) on the motor endplate. To reverse their effect, the concentration of endogenous acetylcholine (ACh) must be increased at the neuromuscular junction to outcompete the blocker. **Cholinesterase inhibitors** (specifically reversible ones like **Neostigmine**) achieve this by inhibiting the enzyme acetylcholinesterase, preventing the breakdown of ACh. This surge in ACh restores normal muscle contraction. **Analysis of Incorrect Options:** * **B & C (Parasympatholytics / Muscarinic antagonists):** These terms are often used interchangeably (e.g., Atropine). They block muscarinic receptors, not nicotinic receptors. While they are administered *alongside* Neostigmine to prevent unwanted bradycardia and salivation, they do not reverse muscle paralysis themselves. * **D (Sympatholytics):** These drugs (e.g., Beta-blockers) inhibit the sympathetic nervous system. They have no direct effect on the neuromuscular junction or the reversal of skeletal muscle relaxation. **High-Yield Clinical Pearls for NEET-PG:** * **The "Atropine Rule":** Neostigmine must always be co-administered with a muscarinic antagonist (Atropine or Glycopyrrolate) to counteract the systemic parasympathetic side effects (bradycardia, bronchospasm, increased secretions) caused by excess ACh. * **Edrophonium:** A rapid-acting cholinesterase inhibitor used in the **Tensilon test** for Myasthenia Gravis, but less commonly used for surgical reversal due to its short duration. * **Sugammadex:** A newer, non-cholinesterase inhibitor agent that reverses Rocuronium/Vecuronium by direct encapsulation (chelation).

Question 284: A patient presented to casualty with acute bronchial asthma after receiving treatment for glaucoma. What is the probable drug that caused this?

A. Timolol (Correct Answer)
B. Betaxolol
C. Latanoprost
D. Anticholinesterase

Explanation: **Explanation:** **1. Why Timolol is Correct:** Timolol is a **non-selective beta-blocker** ($\beta_1$ and $\beta_2$ antagonist) commonly used as first-line topical therapy for open-angle glaucoma to decrease aqueous humor production. Even when administered as eye drops, systemic absorption via the nasolacrimal duct can occur. In patients with reactive airway disease, the blockade of **$\beta_2$ receptors** in the bronchial smooth muscle leads to bronchoconstriction, which can precipitate a life-threatening acute asthma attack. **2. Why the Other Options are Incorrect:** * **Betaxolol:** This is a **cardioselective ($\beta_1$) blocker**. While no beta-blocker is 100% selective, Betaxolol is significantly safer for the lungs than Timolol and is the preferred beta-blocker for glaucoma patients with co-existing respiratory issues. * **Latanoprost:** A Prostaglandin $F_{2\alpha}$ analog. Its primary side effects are local (increased iris pigmentation, eyelash growth, and conjunctival hyperemia). It does not cause bronchospasm. * **Anticholinesterases:** (e.g., Physostigmine, Echothiophate) These are miotics. While they can cause systemic cholinergic side effects (SLUDGE), they are rarely used today and are not the classic "culprit" for sudden asthma exacerbations in glaucoma therapy compared to beta-blockers. **3. High-Yield Clinical Pearls for NEET-PG:** * **Systemic Absorption:** To minimize systemic side effects of glaucoma drops, patients should be taught **nasolacrimal occlusion** (pressing the inner corner of the eye) for 1–2 minutes after instillation. * **Contraindications for Timolol:** Asthma, COPD, Bradycardia, and $2^{nd}$ or $3^{rd}$-degree Heart Block. * **Drug of Choice:** Latanoprost is currently the overall DOC for Open Angle Glaucoma, but Timolol remains a high-yield topic for its side-effect profile.

Question 285: An antimuscarinic drug is being considered for the treatment of an 80-year-old patient. Atropine therapy in the elderly may be hazardous because:

A. Atropine can elevate intraocular pressure in patients with glaucoma (Correct Answer)
B. Atropine frequently causes ventricular tachycardia
C. Urinary retention may be precipitated by atropine in women
D. The elderly are particularly prone to develop dangerous hyperthermia when given Atropine

Explanation: **Explanation:** **Why Option A is Correct:** Atropine is a non-selective muscarinic antagonist. In the eye, it blocks M3 receptors on the **sphincter pupillae** muscle, leading to passive mydriasis (dilation). In patients with narrow-angle glaucoma, this dilation causes the iris tissue to bunch up and block the trabecular meshwork (the drainage angle). This severely impedes the outflow of aqueous humor, leading to a rapid and dangerous rise in **intraocular pressure (IOP)**. Since the elderly have a higher prevalence of undiagnosed narrow-angle glaucoma, Atropine is particularly hazardous. **Analysis of Incorrect Options:** * **Option B:** Atropine typically causes **sinus tachycardia** (by blocking M2 receptors at the SA node). While it can cause arrhythmias in toxic doses, it does not "frequently" cause ventricular tachycardia in standard clinical use. * **Option C:** Urinary retention is a classic side effect, but it is primarily a risk in **elderly men** with Benign Prostatic Hyperplasia (BPH). In women, the risk is significantly lower as they lack a prostate to cause mechanical obstruction. * **Option D:** While Atropine causes hyperthermia (by blocking M3 receptors on sweat glands), this "Atropine fever" is most dangerous in **children and infants**, not the elderly, due to their higher surface-area-to-volume ratio and less developed thermoregulatory centers. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Atropine Poisoning:** "Hot as a hare, Red as a beet, Dry as a bone, Blind as a bat, and Mad as a hatter." * **Drug of Choice (DOC):** Atropine is the DOC for **Symptomatic Bradycardia** and **Organophosphate Poisoning**. * **Contraindications:** Always screen elderly patients for **Glaucoma** and **BPH** before prescribing antimuscarinics. * **Ocular effect:** Atropine causes both **Mydriasis** (dilation) and **Cycloplegia** (loss of accommodation).

Question 286: Which of the following is NOT a direct effect of acetylcholine?

A. Decrease in blood pressure
B. Increase in heart contraction (Correct Answer)
C. Decrease in heart rate
D. Decrease in conduction velocity

Explanation: **Explanation:** Acetylcholine (ACh) is the primary neurotransmitter of the parasympathetic nervous system, acting on **muscarinic (M) receptors** in the heart and vasculature. **Why "Increase in heart contraction" is the correct answer:** Acetylcholine exerts a **negative inotropic effect** (decreased force of contraction). In the heart, ACh binds to **M2 receptors** (G_i coupled), which leads to a decrease in cAMP levels. This results in a decrease in the force of contraction, particularly in the atria. It does **not** increase heart contraction; that is a sympathetic effect mediated by Beta-1 receptors. **Analysis of incorrect options:** * **A. Decrease in blood pressure:** ACh causes vasodilation by acting on **M3 receptors** on vascular endothelial cells. This triggers the release of **Nitric Oxide (EDRF)**, which relaxes vascular smooth muscle, leading to a fall in BP. * **C. Decrease in heart rate:** ACh acts on M2 receptors at the SA node to increase K+ conductance and decrease cAMP, leading to hyperpolarization. This results in a **negative chronotropic effect** (bradycardia). * **D. Decrease in conduction velocity:** ACh slows conduction through the AV node (a **negative dromotropic effect**), which increases the PR interval on an ECG. **NEET-PG High-Yield Pearls:** 1. **Vascular Paradox:** Blood vessels lack parasympathetic innervation, but they *do* possess M3 receptors. Therefore, exogenous ACh causes vasodilation, but vagal stimulation does not significantly affect BP. 2. **M2 Receptors:** Located in the heart (Atria > Ventricles). They are G_i protein-coupled. 3. **Atropine:** The drug of choice to reverse the bradycardia and AV block caused by excessive cholinergic activity.

Question 287: Which drug is given in organophosphate poisoning?

A. Hyoscine
B. Atropine (Correct Answer)
C. Propanthelene
D. Physostigmine

Explanation: **Explanation:** **1. Why Atropine is the Correct Answer:** Organophosphate (OP) compounds inhibit the enzyme **Acetylcholinesterase (AChE)**, leading to a massive accumulation of Acetylcholine (ACh) at muscarinic and nicotinic receptors. This results in a "cholinergic crisis" (SLUDGE syndrome). **Atropine** is a competitive muscarinic antagonist. It crosses the blood-brain barrier and effectively reverses the life-threatening muscarinic effects, such as **bradycardia** and **excessive bronchial secretions**. In OP poisoning, Atropine is titrated until "Atropinization" (clearing of lung secretions and a heart rate >80 bpm) is achieved. **2. Why the Other Options are Incorrect:** * **Hyoscine (Scopolamine):** While it is an anticholinergic, it has prominent central sedative effects and is primarily used for motion sickness or as a pre-anesthetic medication, not for acute poisoning. * **Propantheline:** This is a quaternary ammonium compound. It does not cross the blood-brain barrier and has poor systemic absorption, making it ineffective for the central and severe systemic effects of OP poisoning. * **Physostigmine:** This is a tertiary amine AChE inhibitor. Giving it would worsen OP poisoning by further increasing ACh levels. It is actually the antidote for *Atropine* poisoning. **3. High-Yield Clinical Pearls for NEET-PG:** * **Specific Antidote:** While Atropine treats muscarinic symptoms, **Pralidoxime (2-PAM)** is used as a "Cholinesterase Reactivator" to treat nicotinic symptoms (muscle fasciculations), provided it is given before "enzyme aging" occurs. * **Atropine does NOT reverse muscle paralysis:** It only acts on muscarinic receptors; it has no effect on nicotinic receptors at the neuromuscular junction. * **Mnemonic for OP Poisoning:** **DUMBELS** (Diarrhea, Urination, Miosis, Bradycardia/Bronchospasm, Emesis, Lacrimation, Salivation).

Question 288: Which of the following statements regarding adrenergic receptors is/are true?

A. β1 receptors in the heart stimulate its contractions. (Correct Answer)
B. β2 receptors in the heart stimulate its contractions.
C. β2 receptors are present in smooth muscles.
D. α1 receptors cause preganglionic stimulation.

Explanation: ### Explanation **1. Why Option A is Correct:** The heart primarily expresses **$\beta_1$ adrenergic receptors**. These are Gs-protein coupled receptors. When stimulated by catecholamines (like norepinephrine or epinephrine), they increase intracellular cAMP, leading to increased calcium influx. This results in **positive inotropy** (increased force of contraction), **positive chronotropy** (increased heart rate), and **positive dromotropy** (increased conduction velocity). **2. Why the Other Options are Incorrect:** * **Option B:** While some $\beta_2$ receptors exist in the human heart, they are significantly less numerous than $\beta_1$. The primary and dominant stimulatory effect on cardiac contraction is mediated by **$\beta_1$**. * **Option C:** This statement is technically true in a physiological sense (as $\beta_2$ receptors are found in bronchial, vascular, and uterine smooth muscle), but in the context of this specific single-best-answer question, Option A is the classic, definitive pharmacological fact regarding receptor-organ primary function. (Note: In some exams, this might be a multiple-choice "select all," but $\beta_1$ is the "most" correct textbook answer for cardiac stimulation). * **Option D:** $\alpha_1$ receptors are **postsynaptic** receptors located on effector organs (like vascular smooth muscle, causing vasoconstriction). **$\alpha_2$** receptors are typically the ones involved in **presynaptic** inhibition (decreasing neurotransmitter release), not preganglionic stimulation. **3. NEET-PG High-Yield Pearls:** * **$\beta_1$ Location:** Heart and Juxtaglomerular cells (increases Renin release). * **$\beta_2$ Location:** Lungs (bronchodilation), Blood vessels (vasodilation), Uterus (relaxation/tocolysis), and Liver (glycogenolysis). * **$\beta_3$ Location:** Adipose tissue (lipolysis) and Detrusor muscle (relaxation—target for Mirabegron). * **Mnemonic:** You have **1** Heart ($\beta_1$) and **2** Lungs ($\beta_2$).

Question 289: An example of "autoreceptors" in the CNS is:

A. NMDA receptors
B. Nicotinic receptors
C. Alpha2 receptors (Correct Answer)
D. GABA-C receptors

Explanation: ### Explanation **Concept of Autoreceptors** Autoreceptors are presynaptic receptors located on the nerve terminal that respond to the specific neurotransmitter released by that same neuron. Their primary function is to provide **negative feedback**, inhibiting further release of the neurotransmitter once a sufficient concentration is reached in the synaptic cleft. **Why Alpha-2 ($\alpha_2$) is Correct:** $\alpha_2$ receptors are the classic example of inhibitory presynaptic autoreceptors. In the CNS (and periphery), when norepinephrine (NE) is released, it binds to presynaptic $\alpha_2$ receptors. This leads to the inhibition of adenylyl cyclase and the closing of calcium channels, which effectively **decreases further NE release**. This mechanism is the basis for the action of drugs like Clonidine and Dexmedetomidine. **Analysis of Incorrect Options:** * **NMDA Receptors:** These are ionotropic glutamate receptors located **postsynaptically**. They are involved in excitatory neurotransmission and synaptic plasticity, not autoregulation. * **Nicotinic Receptors:** These are ligand-gated ion channels. While they can be found presynaptically (acting as *heteroreceptors* to modulate other transmitters), they are primarily known as postsynaptic receptors at the neuromuscular junction and autonomic ganglia. * **GABA-C Receptors:** These are ionotropic receptors (now often classified under GABA-A-rho) primarily found in the retina. They are **postsynaptic** inhibitory receptors, not autoreceptors. **High-Yield Clinical Pearls for NEET-PG:** * **Heteroreceptors:** Receptors on a nerve terminal that respond to a *different* neurotransmitter than the one released by that neuron (e.g., $\alpha_2$ receptors on cholinergic terminals). * **Mnemonic:** $\alpha_2$ and $M_2$ are the "Auto-inhibitors" (Presynaptic). * **Clinical Application:** $\alpha_2$ agonists (Clonidine) are used in hypertension and opioid withdrawal because they reduce sympathetic outflow by stimulating these inhibitory autoreceptors.

Question 290: Which of the following is a uroselective a1A blocker?

A. Prazosin
B. Urapidil
C. Tamsulosin (Correct Answer)
D. Terazosin

Explanation: ### Explanation **Correct Answer: C. Tamsulosin** **Mechanism and Concept:** Alpha-1 ($\alpha_1$) receptors are divided into subtypes: $\alpha_{1A}$, $\alpha_{1B}$, and $\alpha_{1D}$. * **$\alpha_{1A}$ receptors** are primarily located in the **prostate, bladder neck, and urethra**. * **$\alpha_{1B}$ receptors** are found predominantly in the **vascular smooth muscle**. **Tamsulosin** is a **uroselective** $\alpha_{1A}$ blocker. Because it specifically targets the receptors in the genitourinary tract rather than the vasculature, it relaxes the smooth muscle of the prostate and bladder neck to improve urine flow in Benign Prostatic Hyperplasia (BPH) without causing significant drops in blood pressure. **Analysis of Incorrect Options:** * **A. Prazosin:** A non-selective, short-acting $\alpha_1$ blocker. It affects both $\alpha_{1A}$ and $\alpha_{1B}$, making it more likely to cause significant hypotension. It is rarely used for BPH today. * **B. Urapidil:** An $\alpha_1$ blocker that also has 5-HT$_{1A}$ agonist activity and weak $\beta$-blocking properties. It is primarily used as an antihypertensive (especially in hypertensive emergencies), not for uroselectivity. * **D. Terazosin:** A long-acting, non-selective $\alpha_1$ blocker. While used for BPH, it lacks subtype selectivity and requires dose titration to avoid the "first-dose effect" (orthostatic hypotension). **NEET-PG High-Yield Pearls:** 1. **Silodosin** is another highly uroselective $\alpha_{1A}$ blocker (even more selective than Tamsulosin). 2. **Side Effect:** Tamsulosin is associated with **Intraoperative Floppy Iris Syndrome (IFIS)**; patients undergoing cataract surgery must inform their surgeon if they are on this drug. 3. **Retrograde Ejaculation:** This is a common side effect of uroselective blockers due to the relaxation of the bladder neck. 4. **Non-selective $\alpha_1$ blockers** (Terazosin, Doxazosin) are preferred if the patient has **both BPH and Hypertension**.

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free